01 1Southwest Synthetic Pharmaceutical
01 1SIMVASTATIN USP
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-08-18
Pay. Date : 2013-09-23
DMF Number : 23425
Submission : 2009-12-29
Status : Active
Type : II
20
Southwest Synthetic Pharmaceutical Corp Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SIMVASTATIN USP, with a corresponding US DMF Number 23425.
Remarkably, this DMF maintains an Active status since its submission on December 29, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 18, 2014, and payment made on September 23, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
